Biodesix, Inc. provided revenue guidance for the year 2024. The company anticipates generating between $65 million to $68 million in total revenue in 2024, representing an approximate 32% to 39% year-over-year growth rate.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | +5.93% | -1.38% | -22.28% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.28% | 208M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
+2.72% | 2.63B | |
-2.98% | 2.64B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2024